HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Retinoic acid-induced developmental defects are mediated by RARbeta/RXR heterodimers in the pharyngeal endoderm.

Abstract
Fusion and hypoplasia of the first two branchial arches, a defect typically observed in retinoic acid (RA) embryopathy, is generated in cultured mouse embryos upon treatment with BMS453, a synthetic compound that exhibits retinoic acid receptor beta (RARbeta) agonistic properties in transfected cells. By contrast, no branchial arch defects are observed following treatment with synthetic retinoids that exhibit RARalpha or RARgamma agonistic properties. The BMS453-induced branchial arch defects are mediated through RAR activation, as they are similar to those generated by a selective pan-RAR agonist, are prevented by a selective pan-RAR antagonist and cannot be mimicked by exposure to a pan-RXR agonist alone. They are enhanced in the presence of a pan-RXR agonist, and cannot be generated in Rarb-null embryos. Furthermore, they are accompanied, in the morphologically altered region, by ectopic expression of Rarb and of several other direct RA target genes. Therefore, craniofacial abnormalities characteristic of the RA embryopathy are mediated through ectopic activation of RARbeta/RXR heterodimers, in which the ligand-dependent activity of RXR is subordinated to that of RARbeta. Endodermal cells lining the first two branchial arches respond to treatment with the RARbeta agonist, in contrast to neural crest cells and ectoderm, which suggests that a faulty endodermal regionalization is directly responsible for RA-induced branchial arch dysmorphologies. Additionally, we provide the first in vivo evidence that the synthetic RARbeta agonist BMS453 exhibits an antagonistic activity on the two other RAR isotypes.
AuthorsNicolas Matt, Norbert B Ghyselinck, Olivia Wendling, Pierre Chambon, Manuel Mark
JournalDevelopment (Cambridge, England) (Development) Vol. 130 Issue 10 Pg. 2083-93 (May 2003) ISSN: 0950-1991 [Print] England
PMID12668623 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • BMS453
  • Protein Isoforms
  • Receptors, Retinoic Acid
  • Retinoid X Receptors
  • Retinoids
  • Transcription Factors
  • retinoic acid receptor beta
  • retinoic acid receptor gamma
  • Tretinoin
Topics
  • Animals
  • Branchial Region (embryology)
  • Craniofacial Abnormalities (metabolism)
  • Dimerization
  • Embryo, Mammalian (anatomy & histology, physiology)
  • Endoderm (metabolism)
  • Gestational Age
  • In Situ Hybridization
  • Mice
  • Mice, Transgenic
  • Morphogenesis (physiology)
  • Pharynx (anatomy & histology, embryology, metabolism)
  • Protein Isoforms (metabolism)
  • Receptors, Retinoic Acid (agonists, antagonists & inhibitors, chemistry, genetics, metabolism)
  • Retinoid X Receptors
  • Retinoids (chemistry, metabolism)
  • Signal Transduction (physiology)
  • Transcription Factors (genetics, metabolism)
  • Transgenes
  • Tretinoin (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: